HIV Citation List: August 19, 2011 - September 1, 2011

Pubmed citations

1. Evaluation of the Synthesis of Sialic Acid-PAMAM Glycodendrimers without the Use of Sugar Protecting Groups, and the Anti-HIV-1 Properties of These Compounds. Clayton, R., J. Hardman, C.C. Labranche, and K.D. McReynolds. Bioconjugate Chemistry. 2011. [Epub ahead of print]; PMID[21859137].

[Pubmed]. HIV_0819-090111.

2. Synthesis and Structure-Activity Relationship of Novel Diarylpyrimidines with Hydromethyl Linker (CH(OH)-DAPYs) as HIV-1 NNRTIs. Gu, S.X., Q.Q. He, S.Q. Yang, X.D. Ma, F.E. Chen, E.D. Clercq, J. Balzarini, and C. Pannecouque. Bioorganic & Medicinal Chemistry. 2011. 19(17): p. 5117-5124; PMID[21824782].

[Pubmed]. HIV_0819-090111.

3. Synthesis of the Anti-HIV Agent (-)-Hyperolactone C by Using Oxonium Ylide Formation-Rearrangement. Hodgson, D.M. and S. Man. Chemistry. 2011. 17(35): p. 9731-9737; PMID[21766363].

[Pubmed]. HIV_0819-090111.

4. Potent anti-HIV-1 Activity of N-HR-derived Peptides Including a Deep Pocket-forming Region without Antagonistic Effects on T-20. Izumi, K., K. Watanabe, S. Oishi, N. Fujii, M. Matsuoka, S.G. Sarafianos, and E.N. Kodama. Antiviral Chemistry & Chemotherapy. 2011. 22(1): p. 51-55; PMID[21860071].

[Pubmed]. HIV_0819-090111.

5. A Novel and Efficient One-pot Synthesis of Symmetrical Diamide (Bis-amidate) Prodrugs of Acyclic Nucleoside Phosphonates and Evaluation of Their Biological Activities. Jansa, P., O. Baszczynski, M. Dracinsky, I. Votruba, Z. Zidek, G. Bahador, G. Stepan, T. Cihlar, R. Mackman, A. Holy, and Z. Janeba. European Journal of Medicinal Chemistry. 2011. 46(9): p. 3748-3754; PMID[21664011].

[Pubmed]. HIV_0819-090111.

6. Efficient Discovery of Potent Anti-HIV Agents Targeting the Tyr181Cys Variant of HIV Reverse Transcriptase. Jorgensen, W.L., M. Bollini, V.V. Thakur, R.A. Domaoal, K.A. Spasov, and K.S. Anderson. Journal of the American Chemical Society. 2011. [Epub ahead of print]; PMID[21853995].

[Pubmed]. HIV_0819-090111.

7. Potent and Broad Anti-HIV-1 Activity Exhibited by a Glycosyl-Phosphatidylinositol-Anchored Peptide Derived from the CDR H3 of Broadly Neutralizing Antibody PG16. Liu, L., M. Wen, W. Wang, S. Wang, L. Yang, Y. Liu, M. Qian, L. Zhang, Y. Shao, J.T. Kimata, and P. Zhou. Journal of Virology. 2011. 85(17): p. 8467-8476; PMID[21715497].

[Pubmed]. HIV_0819-090111.

8. Synthesis and Structural Studies of Pentacycloundecane-based HIV-1 PR Inhibitors: A Hybrid 2D NMR and Docking/QM/MM/MD Approach. Makatini, M.M., K. Petzold, S.N. Sriharsha, N. Ndlovu, M.E. Soliman, B. Honarparvar, R. Parboosing, A. Naidoo, P.I. Arvidsson, Y. Sayed, P. Govender, G.E. Maguire, H.G. Kruger, and T. Govender, European Journal of Medicinal Chemistry. 2011. 46(9): p. 3976-3985; PMID[21741133].

[Pubmed]. HIV_0819-090111.

9. MK-0536 Inhibits HIV-1 Integrases Resistant to Raltegravir. Metifiot, M., B. Johnson, S. Smith, X.Z. Zhao, C. Marchand, T. Burke, S. Hughes, and Y. Pommier. Antimicrobial Agents and Chemotherapy. 2011. [Epub ahead of print]; PMID[21876054].

[Pubmed]. HIV_0819-090111.

10. In Vitro Activity against Plasmodium falciparum of Antiretroviral Drugs. Nsanzabana, C. and P.J. Rosenthal. Antimicrobial Agents and Chemotherapy. 2011. [Epub ahead of print]; PMID[21876053].

[Pubmed]. HIV_0819-090111.

11. Novel Postentry Inhibitor of Human Immunodeficiency Virus Type 1 Replication Screened by Yeast Membrane-associated Two-hybrid System. Urano, E., N. Kuramochi, R. Ichikawa, S.Y. Murayama, K. Miyauchi, H. Tomoda, Y. Takebe, M. Nermut, J. Komano, and Y. Morikawa. Antimicrobial Agents and Chemotherapy. 2011. 55(9): p. 4251-4260; PMID[21746942].

[Pubmed]. HIV_0819-090111.

12. Synthesis, Antiviral Activity, Cytotoxicity and Cellular Pharmacology of l-3'-Azido-2',3'-dideoxypurine nucleosides. Zhang, H.W., M. Detorio, B.D. Herman, S. Solomon, L. Bassit, J.H. Nettles, A. Obikhod, S.J. Tao, J.W. Mellors, N. Sluis-Cremer, S.J. Coats, and R.F. Schinazi. European Journal of Medicinal Chemistry. 2011. 46(9): p. 3832-3844; PMID[21700368].

[Pubmed]. HIV_0819-090111.

13. The New and Less Toxic Protease Inhibitor Saquinavir-NO Maintains anti-HIV-1 Properties in Vitro Indistinguishable from Those of the Parental Compound Saquinavir. Canducci, F., E.R. Ceresola, D. Saita, Y. Al-Abed, G. Garotta, M. Clementi, and F. Nicoletti. Antiviral Research. 2011. 91(3): p. 292-295; PMID[21763726].

[Pubmed]. HIV_0819-090111.

14. Novel Trichomonacidal Spermicides. Jain, A., N. Lal, L. Kumar, V. Verma, R. Kumar, V. Singh, R.K. Mishra, A. Sarswat, S.K. Jain, J.P. Maikhuri, V.L. Sharma, and G. Gupta. Antimicrobial Agents and Chemotherapy. 2011. 55(9): p. 4343-4351; PMID[21709091].

[Pubmed]. HIV_0819-090111.

15. An Efficient Microwave Assisted Synthesis of Novel Class of Rhodanine Derivatives as Potential HIV-1 and JSP-1 Inhibitors. Kamila, S., H. Ankati, and E.R. Biehl. Tetrahedron Letters. 2011. 52(34): p. 4375-4377; PMID[21804651].

[Pubmed]. HIV_0819-090111.

16. Recent Developments of Peptidomimetic HIV-1 Protease Inhibitors. Qiu, X. and Z.P. Liu. Curr Med Chem. 2011. [Epub ahead of print]; PMID[21864279].

[Pubmed]. HIV_0819-090111.

17. Synthesis of New 2'-Deoxy-2'-fluoro-4'-azido nucleoside Analogues as Potent anti-HIV Agents. Wang, Q., W. Hu, S. Wang, Z. Pan, L. Tao, X. Guo, K. Qian, C.H. Chen, K.H. Lee, and J. Chang. European Journal of Medicinal Chemistry. 2011. 46(9): p. 4178-4183; PMID[21745701].

[Pubmed]. HIV_0819-090111.

ISI Web of Knowledge citations:

18. Synthesis and antimicrobial activity of new 1-[(tetrazol-5-yl)methyl] indole derivatives, their 1,2,4-triazole thioglycosides and acyclic analogs. El-Sayed, W.A., R.E.A. Megeid, and H.A.S. Abbas. Archives of Pharmacal Research. 34(7): p. 1085-1096; ISI[000293460700008].

[WOS]. HIV_0819-090111.

19. Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry. Zhao, B., M.K. Mankowski, B.A. Snyder, R.G. Ptak, and P.J. LiWang. Journal of Biological Chemistry. 286(32): p. 28370-28381; ISI[000293557800053].

[WOS]. HIV_0819-090111.

20. Ethyl malonate amides: A diketo acid offspring fragment for HIV integrase inhibition. Serafin, K., P. Mazur, A. Bak, E. Laine, L. Tchertanov, J.F. Mouscadet, and J. Polanski. Bioorganic & Medicinal Chemistry. 19(16): p. 5000-5005; ISI[000293503000031].

[WOS]. HIV_0819-090111.

Patent citations:

21. Preparation of sulfonamide compounds as HIV-1 protease inhibitors. Ali, A., M.D. Altman, S.G. Anjum, H. Cao, S. Chellappan, M.X. Fernandes, M.K. Gilson, V. Kairys, N. King, E. Nalivaika, M. Prabu, T.M. Rana, K.K. Sai, C.A. Schiffer, and B. Tidor. Patent. 2011. 2007-960120 20110178092.

[Patent]. HIV_0819-090111.

22. Methods and products for reawakening retrocyclins. Cole, A.M. Patent. 2011. 2010-699389 20110190385.

[Patent]. HIV_0819-090111.

23. Preparation of indole, benzimidazole, indoline, and isoindoline compounds as HIV-1 fusion inhibitors. Gochin, M. and G. Zhou. Patent. 2011. 2011-6716 20110190343.

[Patent]. HIV_0819-090111.

24. Derivatives of pyridoxine for inhibiting HIV integrase. Stranix, B., J.-E. Bouchard, and G. Milot. Patent. 2011. 2011-CA41 2011088549.

[Patent]. HIV_0819-090111.

25. Antiviral therapy for treatment of HIV infection. Underwood, M.R. Patent. 2011. 2011-US22219 2011094150.

[Patent]. HIV_0819-090111.

26. Anti-viral compounds and compositions. Yao, X. and Z. Ao. Patent. 2011. 2011-CA70 2011088561.

[Patent]. HIV_0819-090111.